BioPharmSignal logoBioPharmSignal

Biotech News

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026

ClearPoint Neuro (CLPT)ClearPoint Neuro2026-06-25 13:46 ESTEarnings

CLPT (CLPT) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is clpt.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Reports First Quarter 2026 Results

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Announces Agreement to Acquire IRRAS

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Reports Third Quarter 2025 Results

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Completes Acquisition of IRRAS

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

CLPTClearPoint Neuro2026-06-25 13:46 EST

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

View all latest news

ClearPoint Neuro

ClearPoint Neuro is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

CLPTClearPoint Neuro2026-06-26 12:01 EST

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

CLPTClearPoint Neuro2026-06-26 12:01 EST

ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint

CLPTClearPoint Neuro2026-06-26 12:01 EST

ClearPoint Neuro Reports First Quarter 2026 Results

CLPTClearPoint Neuro2026-06-26 12:01 EST

ClearPoint Neuro Announces Agreement to Acquire IRRAS

CLPTClearPoint Neuro2026-06-26 12:01 EST

ClearPoint Neuro Reports Third Quarter 2025 Results

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States